Clinical TrialID 379
Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
NCT00002872
Metastatic Cancer
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 379
- Evidence Id
- 379
- Core Evidence Id
- 379
- Source Clinical Trial Id
- 366
- Herb2 Clinical Trial Id
- HBCT000366
- Nct Id
- NCT00002872
- Title
- Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
- Status
- Completed
- Phase
- Phase 3
- Study Result
- No
- Study Condition
- Metastatic Cancer
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: SUPPORTIVE_CARE
- Intervention
- BIOLOGICAL: bleomycin sulfate|DRUG: doxycycline|OTHER: talc
- Intervention Allocation
- Randomized
- Intervention Model
- Intervention Mask
- Intervention Purpose
- Supportive_Care
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 480
- Outcome Measure
- Sponsor Collaborator
- Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|North Central Cancer Treatment Group
- Funded By
- NETWORK
- Location
- Other Id
- CDR0000065154|E-8592|NCCTG-942853|NCI-P96-0076
- Start Date
- 1997-01-10
- Primary Completion Date
- 2003-02
- Completion Date
- First Posted
- 2004-09-02
- Results First Posted
- Last Update Posted
- 2023-06-22
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00002872
- Title Cn
- Title En
- Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
- Bilingual Status
- semi_complete